Latest Regulatory News

Netwealth Group Limited reported a standout FY2025 with net profit rising nearly 40% and funds under administration climbing 28%, underpinning a 37.5% increase in dividends. Strategic fintech acquisitions and robust governance enhancements position the company for sustained growth.

EQT Holdings Limited reported a robust FY25 with a 60% jump in net profit and record funds under management, while completing a major acquisition integration and raising dividends.

Sipa Resources has completed a key heritage survey at its Crown Gold Project near Kalgoorlie, clearing the way for initial drilling expected to begin next month. Meanwhile, assay results from its maiden drilling in South Australia are imminent.

Canterbury Resources has announced a non-underwritten Share Purchase Plan aiming to raise approximately $0.75 million at a 9.1% discount to recent trading prices, supporting exploration and working capital needs.

Ridley Corporation Limited reported a solid FY25 with revenue up 3.1% to $1.3 billion and net profit after tax rising 8.7% to $43.3 million. The company declared a fully franked final dividend of 5.00 cents per share, signaling confidence in its diversified growth strategy.

Telix Pharmaceuticals reported a robust 63% year-over-year revenue increase in H1 2025, driven by strong sales of its precision medicine products and strategic acquisitions. The company is advancing multiple late-stage clinical trials and expanding its global manufacturing footprint.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Telix Pharmaceuticals reported a robust 63% revenue increase in H1 2025, driven by commercial growth and strategic investments, while advancing key clinical trials and maintaining full-year guidance.

Telix Pharmaceuticals reported a robust 63% increase in revenue to $390.4 million for the first half of 2025, driven by strong Illuccix sales and the acquisition of RLS Radiopharmacies. Despite this growth, the company recorded a net loss of $2.3 million, reflecting increased investments and finance costs.

Charter Hall Group reported a robust FY25 with a 7.3% rise in operating earnings per security and a surge in funds under management to $84.3 billion. The group’s strategic equity inflows and development pipeline expansion signal strong momentum heading into FY26.

Insignia Financial has reported a robust FY25 with a 17.6% rise in underlying net profit after tax and a record $330.3 billion in funds under management. The company also unveiled its ambitious strategy to become Australia's leading diversified wealth manager by 2030.

Pepper Money Limited reported a 2% increase in net profit after tax to $47 million for the half-year ended June 2025, driven by strong loan originations and disciplined cost management. The company also raised its interim dividend to 6.4 cents per share, signaling confidence despite a slight dip in net interest income.